Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids.
58 publications have been identified in PubMed for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Research spans Case Report / Case Series (72%), Epidemiology / Natural History (12%), and Review / Meta-Analysis (5%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 42 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:50 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
Disease patterns and progression | 7 | 12% |
Research summaries | 3 | 5% |
Clinical study results | 2 | 3% |
Laboratory research | 2 | 3% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
Bhatia R (2026). [PMID: 42011245](https://pubmed.ncbi.nlm.nih.gov/42011245/). *Lancet Reg Health Southeast Asia*. [Epidemiology / Natural History]
Miyamoto K (2026). [PMID: 41896006](https://pubmed.ncbi.nlm.nih.gov/41896006/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Shen JJR (2026). [PMID: 41123255](https://pubmed.ncbi.nlm.nih.gov/41123255/). *Journal of the European Academy of Dermatology and Venereology : JEADV*. [Epidemiology / Natural History]
Rendón-Garavito AM (2026). [PMID: 41749027](https://pubmed.ncbi.nlm.nih.gov/41749027/). *Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology*. [Case Report / Case Series]
Barriola IE (2026). [PMID: 41718297](https://pubmed.ncbi.nlm.nih.gov/41718297/). *Reports (MDPI)*. [Case Report / Case Series]
Sagawa H (2026). [PMID: 41781714](https://pubmed.ncbi.nlm.nih.gov/41781714/). *Journal of clinical immunology*. [Case Report / Case Series]
Sharma AD (2026). [PMID: 42084967](https://pubmed.ncbi.nlm.nih.gov/42084967/). *Ann Indian Acad Neurol*. [Case Report / Case Series]
Phan A (2026). [PMID: 41401665](https://pubmed.ncbi.nlm.nih.gov/41401665/). *Pediatric neurology*. [Case Report / Case Series]
Shen HY (2026). [PMID: 41756550](https://pubmed.ncbi.nlm.nih.gov/41756550/). *Radiology case reports*. [Case Report / Case Series]
Shen X (2026). [PMID: 41550451](https://pubmed.ncbi.nlm.nih.gov/41550451/). *Case reports in neurology*. [Case Report / Case Series]